Acquired Immunity in Chronic Rhinosinusitis

Bruce Kuang-Huay Tan, Jin Young Min, Kathryn E Hulse*

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

Chronic rhinosinusitis (CRS) is a prevalent disease that is associated with significant costs and quality of life impairments. Currently, patients are classified into subgroups based on clinical characteristics, most often the presence or absence of nasal polyps. However, despite medical and surgical treatment, many of these patients continue to have symptoms. Recent efforts have focused on gaining a more complete understanding of the inflammatory mechanisms that drive pathogenesis in CRS, and it is becoming clear that the inflammatory processes in CRS are quite complex. As our understanding of these complex phenotypes improves, it may become possible to classify patients into endotypes based on unique inflammatory patterns within the sinus mucosa. This information may also lead to the identification of appropriate targeted therapies for different endotypes. This review will discuss our current understanding of endotypes in CRS along with the unique adaptive immune responses that may contribute to these different endotypes and, finally, some potential targeted therapeutics for the next generation of CRS treatment strategies.

Original languageEnglish (US)
Article number49
JournalCurrent Allergy and Asthma Reports
Volume17
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Adaptive Immunity
Nasal Polyps
Therapeutics
Mucous Membrane
Quality of Life
Phenotype
Costs and Cost Analysis

Keywords

  • Antibodies
  • B cells
  • Chronic rhinosinusitis
  • Endotypes
  • Nasal polyps
  • T cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

@article{67bd6571516447f0aca8f93cf84c643f,
title = "Acquired Immunity in Chronic Rhinosinusitis",
abstract = "Chronic rhinosinusitis (CRS) is a prevalent disease that is associated with significant costs and quality of life impairments. Currently, patients are classified into subgroups based on clinical characteristics, most often the presence or absence of nasal polyps. However, despite medical and surgical treatment, many of these patients continue to have symptoms. Recent efforts have focused on gaining a more complete understanding of the inflammatory mechanisms that drive pathogenesis in CRS, and it is becoming clear that the inflammatory processes in CRS are quite complex. As our understanding of these complex phenotypes improves, it may become possible to classify patients into endotypes based on unique inflammatory patterns within the sinus mucosa. This information may also lead to the identification of appropriate targeted therapies for different endotypes. This review will discuss our current understanding of endotypes in CRS along with the unique adaptive immune responses that may contribute to these different endotypes and, finally, some potential targeted therapeutics for the next generation of CRS treatment strategies.",
keywords = "Antibodies, B cells, Chronic rhinosinusitis, Endotypes, Nasal polyps, T cells",
author = "Tan, {Bruce Kuang-Huay} and Min, {Jin Young} and Hulse, {Kathryn E}",
year = "2017",
month = "7",
day = "1",
doi = "10.1007/s11882-017-0715-0",
language = "English (US)",
volume = "17",
journal = "Current Allergy and Asthma Reports",
issn = "1529-7322",
publisher = "Current Medicine Group",
number = "7",

}

Acquired Immunity in Chronic Rhinosinusitis. / Tan, Bruce Kuang-Huay; Min, Jin Young; Hulse, Kathryn E.

In: Current Allergy and Asthma Reports, Vol. 17, No. 7, 49, 01.07.2017.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Acquired Immunity in Chronic Rhinosinusitis

AU - Tan, Bruce Kuang-Huay

AU - Min, Jin Young

AU - Hulse, Kathryn E

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Chronic rhinosinusitis (CRS) is a prevalent disease that is associated with significant costs and quality of life impairments. Currently, patients are classified into subgroups based on clinical characteristics, most often the presence or absence of nasal polyps. However, despite medical and surgical treatment, many of these patients continue to have symptoms. Recent efforts have focused on gaining a more complete understanding of the inflammatory mechanisms that drive pathogenesis in CRS, and it is becoming clear that the inflammatory processes in CRS are quite complex. As our understanding of these complex phenotypes improves, it may become possible to classify patients into endotypes based on unique inflammatory patterns within the sinus mucosa. This information may also lead to the identification of appropriate targeted therapies for different endotypes. This review will discuss our current understanding of endotypes in CRS along with the unique adaptive immune responses that may contribute to these different endotypes and, finally, some potential targeted therapeutics for the next generation of CRS treatment strategies.

AB - Chronic rhinosinusitis (CRS) is a prevalent disease that is associated with significant costs and quality of life impairments. Currently, patients are classified into subgroups based on clinical characteristics, most often the presence or absence of nasal polyps. However, despite medical and surgical treatment, many of these patients continue to have symptoms. Recent efforts have focused on gaining a more complete understanding of the inflammatory mechanisms that drive pathogenesis in CRS, and it is becoming clear that the inflammatory processes in CRS are quite complex. As our understanding of these complex phenotypes improves, it may become possible to classify patients into endotypes based on unique inflammatory patterns within the sinus mucosa. This information may also lead to the identification of appropriate targeted therapies for different endotypes. This review will discuss our current understanding of endotypes in CRS along with the unique adaptive immune responses that may contribute to these different endotypes and, finally, some potential targeted therapeutics for the next generation of CRS treatment strategies.

KW - Antibodies

KW - B cells

KW - Chronic rhinosinusitis

KW - Endotypes

KW - Nasal polyps

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=85021208784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021208784&partnerID=8YFLogxK

U2 - 10.1007/s11882-017-0715-0

DO - 10.1007/s11882-017-0715-0

M3 - Review article

VL - 17

JO - Current Allergy and Asthma Reports

JF - Current Allergy and Asthma Reports

SN - 1529-7322

IS - 7

M1 - 49

ER -